LDL-Proteoglycans Complex as a fatty strek site in atherosclerosis.
低密度脂蛋白-蛋白聚糖复合物作为动脉粥样硬化中的脂肪运动部位。
基本信息
- 批准号:09670741
- 负责人:
- 金额:$ 2.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Objective : It has been reported that low density lipoprotein(LDL) produce insoluble complex with mono-sulfated glycosamino-glycans(GAGs). The complex also has a high affinity with calcium binding proteins namely osteopontin(OPN). We reported that the GAGs are increased in the aorta of experimental models of hypertension in rat. The main aim of this experiment was to investigate how the increased GAGs react with LDL to make insoluble GAGs-LDL complex at the site of atheroscleritic lesion and how the OPN is controled by angiotensin II.Design and Methods : 96-well microtiteation plate was coated with a certain amount of LDL. A limiting quantity of biotin-conjugated proteoglycans(PrG) is allowed to bind to each coated well in competition with different kind of GAGs or lipoproteins applied during incubation period. The amount of biotin-conjugated PrG retained on well was estimated spectrophotometrically by alkaline phosphatase-avidin method. The OPN produced in the culture medium by cultur … More ed vascular smooth muscle cells are measured by Western blotting with monoclonal antibody to OPN.Results : Lp(a) and very low density lipoprotein (VLDL) showed higher affinity with chondroitin-PrG than LDL and high density lipoprotein(HDL) but not significantly. Heparin showed significantly higher affinity with chondroitin-PrG than hiarulonic acid, heparan sulfate and chondroitin sulfate. Divalent cations(calcium, magnesium or manganese) were important to obtain insoluble GAGs-LDL complex in this in vitro model. Angiotensin II increased OPN protein in the medium in accordance with the concentrations between 10ィイD2-11ィエD2M to 10ィイD2-7ィエD2M. Whereas Sar-Ala angiotensin II did not. Angiotensin II receptor blockade supressed OPN increase produced by angiotensin II completely at a concentration of 10ィイD2-5ィエD2M.Conclusions : Our results showed that GAGs and divalent cations are essential for LDL to remain in the atherosclerotic lesion. Hypertension might contribute to make the complex by enhance production of chondroitin sulfate in the aortic media. Angiotensin II might enhance hydroxyapatite formation in hypertensive atherosclerotic lesion. Less
目的:低密度脂蛋白(LDL)与单硫酸化糖胺聚糖(GAG)形成不溶性复合物。该复合物还与钙结合蛋白即骨桥蛋白(OPN)具有高亲和力。本文报道了实验性高血压大鼠主动脉中糖胺聚糖的含量增加。本实验的主要目的是研究在动脉粥样硬化病变部位增加的糖胺聚糖(GAGs)如何与低密度脂蛋白(LDL)反应形成不溶性的GAGs-LDL复合物,以及血管紧张素Ⅱ(Ang Ⅱ)如何调控骨桥蛋白(OPN)。允许有限量的生物素缀合的蛋白聚糖(PrG)与在孵育期间应用的不同种类的GAG或脂蛋白竞争结合到每个包被的孔。通过碱性磷酸酶-亲和素法,通过生物素定量法估计保留在孔上的生物素缀合的PrG的量。培养液中产生的骨桥蛋白, ...更多信息 结果:Lp(a)和极低密度脂蛋白(VLDL)与软骨素-PrG的亲和力高于低密度脂蛋白(LDL)和高密度脂蛋白(HDL),但差异不显著。肝素与软骨素-PrG的亲和力显著高于黄曲霉酸、硫酸乙酰肝素和硫酸软骨素。二价阳离子(钙、镁或锰)对于在该体外模型中获得不溶性GAGs-LDL复合物是重要的。血管紧张素II在10 μ mol/L D2-11 μ mol/L D2 M至10 μ mol/L D2-7 μ mol/L D2 M浓度范围内增加培养液中OPN蛋白的表达。而Sar-Ala血管紧张素II则没有。在10 μ mol/L D2-5 μ mol/L D2 M浓度下,血管紧张素Ⅱ受体阻断剂完全抑制血管紧张素Ⅱ引起的OPN增加。结论:GAGs和二价阳离子是LDL在动脉粥样硬化病变中滞留的必要条件。高血压可能通过增加主动脉中膜硫酸软骨素的产生而促进复合物的形成。血管紧张素II可能促进高血压动脉粥样硬化病变中羟基磷灰石的形成。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
S.Booka,M.Hamada: "Glycosaminoglycans enhmces lipid accumulation in hypertension" J.of Hypertension. 61s. 321 (1998)
S.Booka,M.Hamada:“糖胺聚糖增强高血压中的脂质积累”J.of Hypertension。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAMADA Masanori其他文献
HAMADA Masanori的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAMADA Masanori', 18)}}的其他基金
Study on liquefaction and lateral flow countermeasure technique due to use of wood
木材液化及侧流对策技术研究
- 批准号:
20246078 - 财政年份:2008
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
A study on Earthquake Resistance of Foundations against the flow of Liquefied Grond
地基抗液化土流抗震研究
- 批准号:
17206049 - 财政年份:2005
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Study on Earthquake Resistance of Infrastructures against Fault-Induced Ground Surfece Ruptures
基础设施抗断层地表破裂的抗震研究
- 批准号:
13305032 - 财政年份:2001
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of Assessment System for Liquefaction-Induced Ground Flow and Its Caused Damage to Lifeline
液化地流及其生命线损害评估系统的研制
- 批准号:
13555135 - 财政年份:2001
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A study on Earthquake Resistance of Pile Foundations against Liquefaction-Induced Ground Flow
桩基液化地流抗震研究
- 批准号:
11650495 - 财政年份:1999
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Study on Liquefaction-Induced Ground Large Displacement
液化引起的地面大位移研究
- 批准号:
08455213 - 财政年份:1996
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Effect of serum from patients with restenosis after PTCA on migration-stimulating activity of cultured smooth muscle cells.
PTCA 术后再狭窄患者血清对培养的平滑肌细胞迁移刺激活性的影响。
- 批准号:
06670739 - 财政年份:1994
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Effect of Liquefaction on Lifeline Facilities and Earthquake Resistant Design
液化对生命线设施及抗震设计的影响
- 批准号:
03044129 - 财政年份:1991
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for international Scientific Research
Study of Earthquake Disaster Prevention of Waterfront
滨水区地震防灾研究
- 批准号:
01302044 - 财政年份:1989
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for Co-operative Research (A)
Study on Liquefaction-Induced Ground Movement and Damage to In-ground Structures
液化引起的地面移动及地下结构损伤研究
- 批准号:
63460158 - 财政年份:1988
- 资助金额:
$ 2.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
胞外多糖分子在心脏发育过程中对关键信号通路的调节作用
- 批准号:30971660
- 批准年份:2009
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Mass spectrometry imaging of glycosaminoglycans in biological samples
生物样品中糖胺聚糖的质谱成像
- 批准号:
EP/Y002423/1 - 财政年份:2024
- 资助金额:
$ 2.05万 - 项目类别:
Research Grant
Investigating the molecular mechanisms of glycosaminoglycan assembly
研究糖胺聚糖组装的分子机制
- 批准号:
10715380 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Melanoma Immunotherapy with GPR182 blockade
阻断 GPR182 的黑色素瘤免疫疗法
- 批准号:
10585749 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Repetitive Stretch-Induced Myocardial Stiffening in Chronic Coronary Artery Disease
慢性冠状动脉疾病中反复牵拉引起的心肌硬化
- 批准号:
10588929 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Demystify Heparan Sulfate–Sclerostin Interactions in Bone Formation
揭秘硫酸乙酰肝素与硬化素在骨形成中的相互作用
- 批准号:
10593214 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Layilin as a modulator of platelet activation and thromboinflammation
Layilin 作为血小板活化和血栓炎症调节剂
- 批准号:
10607168 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
- 批准号:
10667165 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis
粘多糖贮积症遗传变异的细胞表型
- 批准号:
10638709 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Development of Catalytic Glycosylations and Biologically Important Glycosaminoglycans
催化糖基化和具有生物学重要性的糖胺聚糖的发展
- 批准号:
10622180 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:
Pulmonary endothelium targeted adenoviral gene therapy for the correction of mucopolysaccharidosis type I
肺内皮靶向腺病毒基因治疗纠正 I 型粘多糖贮积症
- 批准号:
10678053 - 财政年份:2023
- 资助金额:
$ 2.05万 - 项目类别:














{{item.name}}会员




